41 results
8-K
EX-10.1
APTO
Aptose Biosciences Inc
3 Jun 24
Entry into a Material Definitive Agreement
10:32am
other expenses incurred by such party incident to the negotiation, preparation, execution, delivery and performance of this Agreement. The Company shall
8-K
EX-1.1
APTO
Aptose Biosciences Inc
29 Jan 24
Entry into a Material Definitive Agreement
9:44pm
are consummated or this Agreement is terminated, all costs and expenses incident to the public offering of the Securities and the performance … to the Underwriters; and (vi) all reasonable out-of-pocket costs and expenses incident to the offering and the performance of the obligations of the Representative
424B4
APTO
Aptose Biosciences Inc
26 Jan 24
Prospectus supplement with pricing info
5:30pm
to protect against cyber-attacks.
Disruptions due to cyber security incidents could adversely affect our business. In particular, a cyber security incident
424B3
zu8ejaw84dzrxrfr
6 Jul 23
Prospectus supplement
4:01pm
S-1
t5s0wjvni 0be3e
16 Jun 23
IPO registration
6:42pm
8-K
EX-10.2
i71qm93ewx
26 May 23
Entry into a Material Definitive Agreement
4:01pm
8-K
EX-10.1
m6eo38vkgavz7n
12 Dec 22
Entry into a Material Definitive Agreement
8:00am
8-K
EX-1.1
r7ct2br
16 Jul 20
Aptose Announces Pricing of Public Offering of Common Shares
4:05pm
8-K
EX-10.1
e72v9qzmga0sl
5 May 20
Aptose Reports Results for the First Quarter 2020
5:01pm
8-K
EX-1.1
p65kpd1p8s 0n5ipih
17 Dec 19
Aptose Announces Pricing of Public Offering of Common Shares
2:27pm
8-K
EX-1.1
31jc80x8 4zc1t
30 May 19
Aptose Announces Pricing of Public Offering of Common Shares
4:13pm
8-K
EX-10.1
6wd6bkqdde
24 May 19
Entry into a Material Definitive Agreement
5:20pm
424B5
962afy8amnki
13 May 19
Prospectus supplement for primary offering
12:00am